Medicure (MCUJF) Net Margin (2009 - 2026)

Medicure's (MCUJF) quarterly Net Margin came in at 5.11% in Q1 2026, down 1638.0% year-on-year from 0.33% in Q1 2025, and up 95.48% quarter-over-quarter from 113.02% in Q4 2025.

Medicure (MCUJF) Net Margin (2009 - 2026) Analysis & Trends

Medicure's Net Margin history runs 18 years deep, the most recent figure standing at 5.11% for Q1 2026.

  • On a quarterly basis, Net Margin fell 1638.0% year-over-year to 5.11% in Q1 2026; TTM through Mar 2026 was 38.84%, a 3655.0% decrease from a year earlier, with the FY2025 full-year figure at 24.6%, down 1985.0% from the prior year.
  • Net Margin advanced to 5.11% in Q1 2026 per MCUJF's latest filing, from 113.02% in the prior quarter.
  • Across five years, Net Margin topped out at 85.43% in Q4 2022 and bottomed at 113.02% in Q4 2025.
  • The 5-year median for Net Margin is 1.29% (2023), against an average of 3.87%.
  • Across the five-year window, Net Margin jumped 3185 bps in 2022 and slumped 10996 bps in 2023, its largest moves.
  • Year by year, Net Margin stood at 85.43% in 2022, then plunged by 129 bps to 24.53% in 2023, then surged by 62 bps to 9.38% in 2024, then slumped by 1105 bps to 113.02% in 2025, then soared by 95 bps to 5.11% in 2026.
  • Per Business Quant, the three latest MCUJF Net Margin figures stand at 5.11% (Q1 2026), 113.02% (Q4 2025), and 17.11% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 9.29%
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 26.57%
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -33.66%
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 35.18%
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 5.03%
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 24.30%
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 4.16%
10 Medicure 8.77 Mn 7.64 Mn 2.57 Mn -5.11%

Historic Data

Download Data
DateValue
Mar 31, 2026 -5.11%
Dec 31, 2025 -113.02%
Sep 30, 2025 -17.11%
Jun 30, 2025 -11.79%
Mar 31, 2025 11.27%
Dec 31, 2024 -9.38%
Sep 30, 2024 13.20%
Jun 30, 2024 -23.56%
Mar 31, 2024 0.90%
Dec 31, 2023 -24.53%
Sep 30, 2023 1.68%
Jun 30, 2023 4.22%
Mar 31, 2023 4.83%
Dec 31, 2022 85.43%
Sep 30, 2022 14.68%
Jun 30, 2022 6.32%
Sep 30, 2021 -17.17%
Jun 30, 2021 9.85%
Mar 31, 2021 21.23%
Dec 31, 2020 -393.14%